Open original FDA record ↗Recall record
- FDA identifier
- Z-1697-2024
- Company in FDA record
- Covidien, LP
- FDA classification date
- Apr 29, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
One lot of product was exposed to more than the approved number of Ethylene Oxide (EO) sterilization cycles. This may decrease the tensile strength of the sutures over time, which could result in harms such as wound dehiscence, hemorrhage, blood loss, bleeding, tissue breakdown, peritonitis, unspecified infection, vision loss (when used in ophthalmic application), and/or prolonged surgery.
Source facts
- Action
- On January 25, 2024, Medtronic issued an expansion to their earlier recall for sutures (RES 93768) concerning gamma sterilization. As part of that expansion, there was an additional lot of product which was exposed to more than the approved number of EO sterilization cycles, which is covered in this recall, RES 94351. The issue was communicated to affected consignees via letters. Consignees are asked to return any affected product they may have, forward this notification to those who need to be aware within the organization and to any location which the devices have been transferred.
- Initiated
- 2024-01-25
- Root cause
- Process control
- Distribution
- International distribution in the countries of Portugal and Italy.
- Recall number
- Z-1697-2024
- Recall status
- Open, Classified
- CDRH record ID
- 206993
- FDA classified
- 2024-04-29
- Recall event number
- 94351